dr vahdat on recent data on adcs in metastatic tnbc
Published 1 month ago • 56 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
0:57
dr. linda vahdat on glembatumumab vedotin as a treatment in triple negative breast cancer
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
1:25
dato-dxd: a new adc on the block
-
1:49
the latest clinical research on adcs in breast cancer
-
1:02:35
integrating antibody-drug conjugates into mgmt of hr and triple-negative metastatic breast cancer
-
1:30
meet dr. linda t. vahdat, md: breast cancer and hematology oncology
-
8:33
adcs & checkpoint inhibitor combinations in tnbc
-
24:23
dr. hope rugo: adc's current clinical evidence
-
6:20
antibody-drug conjugates for tnbc
-
2:02
dr. soliman the utility of adcs in breast cancer
-
0:59
dr. accordino on data from the pearl trial in hr /her2- metastatic breast cancer
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
2:07
emerging toxicities associated with adcs
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
2:02
metastatic breast cancer treatments in development
-
1:18
the advantage of adcs for the treatment of brain metastases
-
1:49
dr. angela demichele on selecting best therapies in tnbc
-
57:18
translating progress with immunotherapies and targeted agents into improved outcomes in tnbc